Clinical trial
N-of-1 Trials to Promote Deprescribing in Older Adults With Transthyretin Cardiac Amyloidosis
NCT05019027 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- N-of-1 Trials to Promote Deprescribing in Older Adults With Transthyretin Cardiac Amyloidosis
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2024
- Completion date
- June 4, 2026
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac amyloidosis, heart diseases, ttr cardiac amyloidosis